Ha Eun-Sol, Ok Jinsu, Noh Jongmin, Jeong Hee-Young, Choo Gwang-Ho, Jung Young-Suk, Baek In-Hwan, Kim Jeong-Soo, Cho Wonkyung, Hwang Sung-Joo, Kim Min-Soo
College of Pharmacy, Pusan National University, 2, Busandaehak-ro 63beon-gil, Geumjeong-gu, Busan 609-735, Republic of Korea.
College of Pharmacy, Kyungsung University, Daeyeon-dong, Nam-gu, Busan 608-736, Republic of Korea.
Int J Biol Macromol. 2015 Jan;72:1473-8. doi: 10.1016/j.ijbiomac.2014.09.063. Epub 2014 Oct 14.
This study was undertaken to improve the solubility and dissolution of a poorly water-soluble drug, celecoxib, by surface modification with a hydrophilic polymer and a surfactant by using a spray-drying technique. Based on the preliminary solubility tests, hydroxypropylmethyl cellulose (HPMC) and D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) were selected as the polymer and the surfactant, respectively. A novel surface-modified celecoxib microparticle was successfully fabricated using a spray-drying process with water, HPMC, and TPGS, and without the use of an organic solvent. The physicochemical properties of the surface-modified celecoxib microparticle were characterized using scanning electron microscopy (SEM), powder X-ray diffraction (PXRD), a particle size analyzer, and contact angle determination. The formulation with drug/HPMC/TPGS at the weight ratio of 1:0.5:1.5 was determined to be the most effective composition in the preparation of the surface-modified celecoxib microparticle, based on the results of wettability, solubility, and dissolution studies. We found that the surface modification of microparticles with HPMC and TPGS can be an effective formulation strategy for new dosage forms of poorly water-soluble active pharmaceutical ingredients (APIs) to provide higher solubility and dissolution.
本研究旨在通过使用喷雾干燥技术,用亲水性聚合物和表面活性剂对水难溶性药物塞来昔布进行表面改性,以提高其溶解度和溶出度。基于初步的溶解度测试,分别选择羟丙基甲基纤维素(HPMC)和D-α-生育酚聚乙二醇1000琥珀酸酯(TPGS)作为聚合物和表面活性剂。使用水、HPMC和TPGS,通过喷雾干燥工艺成功制备了一种新型的表面改性塞来昔布微粒,且未使用有机溶剂。使用扫描电子显微镜(SEM)、粉末X射线衍射(PXRD)、粒度分析仪和接触角测定对表面改性塞来昔布微粒的物理化学性质进行了表征。基于润湿性、溶解度和溶出度研究的结果,确定药物/HPMC/TPGS重量比为1:0.5:1.5的制剂是制备表面改性塞来昔布微粒最有效的组合物。我们发现,用HPMC和TPGS对微粒进行表面改性可以成为一种有效的制剂策略,用于水难溶性活性药物成分(API)的新剂型,以提供更高的溶解度和溶出度。